Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

September 01, 1984; Volume 230,Issue 3

Article

  • You have access
    Effect of Aminoglycoside Antibiotics on Cellular Functions of Kidney Epithelial Cell Line (LLC-PK1): A Model System for Aminoglycoside Nephrotoxicity
    RYOHEI HORI, KYOKO YAMAMOTO, HIDEYUKI SAITO, MICHIAKI KOHNO and KEN-ICHI INUI
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 742-748;
  • You have access
    Neurogenic and myogenic contractile responses of dog mesenteric arteries to reduced K+ concentration and their interactions with ouabain.
    S Hayashi and M K Park
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 527-533;
  • You have access
    Studies on the relationship between contraction and mediator release produced by ovalbumin in superfused trachea isolated from the actively sensitized guinea pig.
    R I Fishleder and C K Buckner
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 534-540;
  • You have access
    Effects of opioids on accuracy of a fixed-ratio discrimination in monkeys and rats.
    J M Moerschbaecher, J Mastropaolo, P J Winsauer and D M Thompson
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 541-549;
  • You have access
    Production and antagonism of cutaneous vascular permeability in the guinea pig in response to histamine, leukotrienes and A23187.
    L E Rinkema, K G Bemis and J H Fleisch
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 550-557;
  • You have access
    Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
    R A Hahn and B R MacDonald
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 558-568;
  • You have access
    Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO].
    G E Martin, M Williams, D J Pettibone, G G Yarbrough, B V Clineschmidt and J H Jones
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 569-576;
  • You have access
    Assessment of the functional role of brain adrenergic neurons: chronic effects of phenylethanolamine N-methyltransferase inhibitors and alpha adrenergic receptor antagonists on brain norepinephrine metabolism.
    J M Stolk, G Vantini, B D Perry, R B Guchhait and D C U'Prichard
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 577-586;
  • You have access
    Possible relationship between receptor reserve and the differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by calcium channel antagonists in the pithed rat.
    R R Ruffolo, E L Morgan and K Messick
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 587-594;
  • You have access
    Interactions of epinephrine, norepinephrine, dopamine and their corresponding alpha-methyl-substituted derivatives with alpha and beta adrenoceptors in the pithed rat.
    R R Ruffolo, M R Goldberg and E L Morgan
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 595-600;
  • You have access
    Interference by prostaglandin E2 with the phosphaturic effects of nonhormonal agents.
    T O Pitts, J H Dominguez and J B Puschett
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 601-606;
  • You have access
    Effects of metal cations and calmodulin antagonists on [3H] nitrendipine binding in smooth and cardiac muscle.
    E M Luchowski, F Yousif, D J Triggle, S C Maurer, J G Sarmiento and R A Janis
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 607-613;
  • You have access
    Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta adrenergic receptors.
    R N Pittman, E E Reynolds and P B Molinoff
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 614-618;
  • You have access
    A study of the novel synthetic analog (+/-)-depentylperhydrohistrionicotoxin on the nicotinic receptor-ion channel complex.
    M A Maleque, K Takahashi, B Witkop, A Brossi and E X Albuquerque
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 619-626;
  • You have access
    Kinetics of drug action in disease states. II. Effect of experimental renal dysfunction on phenobarbital concentrations in rats at onset of loss of righting reflect.
    M Danhof, M Hisaoka and G Levy
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 627-631;
  • You have access
    Cardiac electrophysiologic actions of KB-944 (Fostedil), a new calcium antagonist, in the anesthetized dog.
    E Patterson, D G Montgomery, J J Lynch and B R Lucchesi
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 632-640;
  • You have access
    Effects of the highly selective kappa opioid, U-50, 488, on renal function in the anesthetized dog.
    G R Slizgi, C J Taylor and J H Ludens
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 641-645;
  • You have access
    Negative inotropic effect of leukotrienes: leukotrienes C4 and D4 inhibit calcium-dependent contractile responses in potassium-depolarized guinea-pig myocardium.
    Y Hattori and R Levi
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 646-651;
  • You have access
    Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine.
    C P France, A E Jacobson and J H Woods
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 652-657;
  • You have access
    Patterns of ethanol consumption as a function of the schedule of ethanol access.
    H Marcucella, I Munro and J S MacDonall
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 658-664;
  • You have access
    Molecular basis for the pharmacological actions of Clostridium botulinum type C2 toxin.
    L L Simpson
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 665-669;
  • You have access
    Characterization of the enhanced paw edema response to carrageenan and dextran in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats.
    L B Katz, H M Theobald, R C Bookstaff and R E Peterson
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 670-677;
  • You have access
    Intravenous self-administration of dopamine receptor agonists by rhesus monkeys.
    W L Woolverton, L I Goldberg and J Z Ginos
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 678-683;
  • You have access
    Interaction of opiate receptor binding sites and guanine nucleotide regulatory sites: selective protection from N-ethylmaleimide.
    S R Childers
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 684-691;
  • You have access
    O2-sensitivity of beta adrenergic responsiveness in isolated bovine and porcine coronary arteries.
    G Rubanyi and R J Paul
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 692-698;
  • You have access
    Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein.
    N A Flavahan, T J Rimele, J P Cooke and P M Vanhoutte
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 699-705;
  • You have access
    Probenecid reduces cochlear effects and perilymph penetration of furosemide in chinchilla.
    L P Rybak, T P Green, S K Juhn and T Morizono
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 706-709;
  • You have access
    Structure-activity relationship between guanidine alkyl derivatives and norepinephrine release: site(s) and mechanism(s) of action.
    J A Hirsch
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 710-717;
  • You have access
    Influence of route of hepatic administration on drug availability.
    A B Ahmad, P N Bennett and M Rowland
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 718-725;
  • You have access
    Effect of aminoglycoside antibiotics on cellular functions of kidney epithelial cell line (LLC-PK1): a model system for aminoglycoside nephrotoxicity.
    R Hori, K Yamamoto, H Saito, M Kohno and K Inui
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 724-728;
  • You have access
    Role of the gut flora in the reduction of sulfinpyrazone in humans.
    H A Strong, J Oates, J Sembi, A G Renwick and C F George
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 726-732;
  • You have access
    Tissue distribution of poly(hexyl 2-cyanoacrylate) nanoparticles coated with monoclonal antibodies in mice bearing human tumor xenografts.
    L Illum, P D Jones, R W Baldwin and S S Davis
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 733-736;
  • You have access
    Effects on calmodulin of bepridil, an antianginal agent.
    H Itoh, T Ishikawa and H Hidaka
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 737-741;
  • You have access
    Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    F Marceau and T E Hugli
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 749-754;
  • You have access
    Trypan blue uptake as a new method to investigate hepatotoxicity in periportal and pericentral regions of the liver lobule: studies with allyl alcohol in the perfused liver.
    S A Belinsky, J A Popp, F C Kauffman and R G Thurman
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 755-760;
  • You have access
    Effects of beta-naphthoflavone and 3-methylcholanthrene administered to pregnant rats on steroid metabolism in the isolated basal zone of the placenta.
    K T Shiverick, E Ortiz, C Fuhrman-Lane and P Crowley
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 761-767;
  • You have access
    Characterization of benzodiazepine receptor changes in substantia nigra, globus pallidus and entopeduncular nucleus after striatal lesions.
    H S Pan, J B Penney and A B Young
    Journal of Pharmacology and Experimental Therapeutics September 1984, 230 (3) 768-775;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 230, Issue 3
1 Sep 1984
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Read
Loading
  • Manifestations of METH Neurotoxicity
  • Ocular Drug Delivery: Past, Present, and Future
  • Noradrenergic Mechanisms in Fentanyl Rapid Death
  • Acalabrutinib: A Differentiated Covalent BTK Inhibitor
  • Cannabis Therapy for Refractory Epilepsy
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics